RAB5A in triple-negative breast cancer: a critical role in macrophage reshaping in an exosomal miR-21-dependent

Lei Qiao1, Chao Dong1, Wenlei Jia1

  • 1Department of Breast and Thyroid Surgery, Xinjiang Medical University Affiliated Tumor Hospital, Urumqi, Xinjiang Uygur Autonomous Region, China.

PubMed

Insights

RAB5A depletion in triple-negative breast cancer (TNBC) cells reduces exosome secretion and M2 macrophage polarization. This pathway involves exosomal miR-21 targeting Pellino-1, impacting tumor growth and macrophage recruitment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Triple-negative breast cancer (TNBC) presents a poor prognosis and limited therapeutic options.
  • Identifying molecular drivers is crucial for developing targeted TNBC therapies.

Purpose of the Study:

  • To investigate the role of RAB5A in TNBC progression and its impact on macrophage polarization.
  • To elucidate the molecular mechanisms underlying RAB5A-mediated effects in TNBC.

Main Methods:

  • Depletion of RAB5A in TNBC cells.
  • Analysis of exosome secretion and miRNA profiling.
  • Macrophage polarization assays (M2 phenotype).
  • In vitro and in vivo (xenograft) experiments to assess tumor growth and macrophage recruitment.

Main Results:

  • RAB5A depletion suppressed exosome secretion and M2 macrophage polarization.
  • Exosomal miR-21 was identified as a key mediator in RAB5A-driven macrophage polarization.
  • miR-21 targeted Pellino-1 (PELI1), influencing M2 polarization.
  • RAB5A-depleted TNBC cells showed reduced tumor cell proliferation, migration, and invasion.
  • In vivo studies confirmed reduced tumor formation and macrophage recruitment with RAB5A knockdown.

Conclusions:

  • RAB5A influences TNBC progression via exosomal miR-21-mediated macrophage polarization.
  • This pathway represents a potential therapeutic target for TNBC treatment.
  • RAB5A and exosome-based strategies offer a basis for novel therapeutic approaches.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K